Early Alzheimer’s Detection through Blood Testing: Relevance to Aging Populations in Low- and Middle-income Countries
Alzheimer’s disease is a leading cause of dementia worldwide, with timely diagnosis remaining a challenge, especially in low- and middle-income countries (LMICs). Limited access to specialized services, high costs of neuroimaging and cerebrospinal fluid analyses, and low public awareness delay recognition and treatment...